Pamela R. Drullinsky, MD

About Me

I am a board-certified medical oncologist with expertise in breast cancer, non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, and chronic lymphocytic leukemia. I am a member of MSK’s breast cancer and lymphoma disease management teams.

Read more

After completing oncology and hematology training at MSK, I joined the team at MSK Rockville Centre when it opened, in 1998. My colleagues and I offer a multidisciplinary approach utilizing the most recent advanced treatments in medical oncology and state-of-the-art radiation oncology. We also offer novel chemotherapy, targeted therapies, and monoclonal antibody therapies as well as genetic testing — which can help individualize treatment — closer to home.

As part of our research efforts, we are actively enrolling patients in a growing number of clinical trials at MSK Rockville Centre, allowing patients to receive the most advanced care closer to home on Long Island. We offer a warm, intimate environment, where doctors, nurses, and support staff collaborate with local physicians and facilities to take care of the medical, social, nutritional, and psychological needs of our patients. 

  • Clinical Expertise: General Medical Oncology; Breast Cancer; Hematologic Malignancies
  • Languages Spoken: English; Spanish
  • Education: MD, Sackler School of Medicine (Tel Aviv)
  • Residencies: Mount Sinai Medical Center (New York)
  • Fellowships: Memorial Sloan Kettering Cancer Center
  • Board Certifications: Medical Oncology

Appointments Available

Making an appointment

Call 800-525-2225

Publications

Visit PubMed for a full listing of Pamela R. Drullinsky’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more